Déjà vu All Over Again: Retreatment of HCV Direct Acting Antivirals Failures-Same Satisfactory Results, Same Unanswered Questions
Clin Infect Dis
.
2021 Nov 2;73(9):e3296-e3299.
doi: 10.1093/cid/ciaa1329.
Authors
Mark Sulkowski
1
,
David Wyles
2
Affiliations
1
Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
2
Denver Health Medical Center, Denver, Colorado, USA.
PMID:
32887999
PMCID:
PMC8563175
DOI:
10.1093/cid/ciaa1329
No abstract available
Keywords:
Direct Acting Antivirals; hepatitis C; resistance associated substitutions; retreatment.
Publication types
Editorial
Comment
MeSH terms
Antiviral Agents* / therapeutic use
Hepacivirus
Hepatitis C, Chronic* / drug therapy
Humans
Retreatment
Substances
Antiviral Agents
Grants and funding
K24 DA034621/DA/NIDA NIH HHS/United States
R01 DA016065/DA/NIDA NIH HHS/United States